Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi-Lepri

Showing results (111-120 of 244) with videos related to

Pageof 25
Sort By:
Open Forum Infectious Diseases|January 15, 2021
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected PatientsVincenzo Malagnino, Carlotta Cerva, Antonella Cingolani, et al.
Viruses|August 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWHAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.
Archives of Internal Medicine|October 11, 2002
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjectsAndrea De Luca, Roberto Bugarini, Alessandro Cozzi Lepri, et al.
The Journal of Infectious Diseases|May 15, 2004
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failedCarlo Federico Perno, Alessandro Cozzi-Lepri, Federica Forbici, et al.
Antiviral Therapy|March 9, 2005
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individualsGiorgio Antonucci, Enrico Girardi, Alessandro Cozzi-Lepri, et al.
International Journal of Antimicrobial Agents|July 22, 2021
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapyRoberta Gagliardini, Nicola Gianotti, Franco Maggiolo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 24, 2019
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort StudySebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Antiviral Therapy|October 26, 2011
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcomeAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2014
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failureGabriella Rozera, Isabella Abbate, Emanuela Giombini, et al.
Pageof 25

Showing results (111-120 of 244) with videos related to

Sort By:
Pageof 25
Open Forum Infectious Diseases|January 15, 2021
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected PatientsVincenzo Malagnino, Carlotta Cerva, Antonella Cingolani, et al.
Viruses|August 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWHAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.
Archives of Internal Medicine|October 11, 2002
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjectsAndrea De Luca, Roberto Bugarini, Alessandro Cozzi Lepri, et al.
The Journal of Infectious Diseases|May 15, 2004
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failedCarlo Federico Perno, Alessandro Cozzi-Lepri, Federica Forbici, et al.
Antiviral Therapy|March 9, 2005
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individualsGiorgio Antonucci, Enrico Girardi, Alessandro Cozzi-Lepri, et al.
International Journal of Antimicrobial Agents|July 22, 2021
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapyRoberta Gagliardini, Nicola Gianotti, Franco Maggiolo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 24, 2019
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort StudySebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Antiviral Therapy|October 26, 2011
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcomeAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2014
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failureGabriella Rozera, Isabella Abbate, Emanuela Giombini, et al.
Pageof 25